TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.

Cameron J Turtle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.